Molecular Instruments Launches Ambient-Temperature HCR™ Pro RNA-ISH on BOND-III for Clinical Automation
Molecular Instruments introduces the HCR™ Pro RNA-ISH on the BOND-III, a clinical-grade solution designed to enhance RNA-ISH workflows by operating at ambient temperatures, thereby preserving patient samples and reducing variability.
Theia Market Signal Identification - AI Assisted
Molecular Instruments has launched the HCR™ Pro RNA-ISH on the BOND-III, a new clinical-grade solution designed for ambient-temperature operation. This innovation reduces heat-driven variability, preserves patient samples, and enables scalable automation in pathology workflows.
HCR™ Pro eliminates the need for enzymatic digestion and elevated temperatures, ensuring high signal-to-background performance in FFPE tissues. The integration into existing BOND-III workflows is seamless, allowing laboratories to enhance RNA-ISH capacity without software updates. This solution is aimed at clinical applications where tissue integrity and consistent results are crucial.
Comments